MUC5AC and neoplasm: In particular, CK20, MUC2, MUC5AC, MUC6 and β-catenin showed disparate expression patterns that may in part be ascribed to clinicopathologic factors such as tumor location, mucinous components, differentiation, and MSI-status, conceivably reflecting diverse underlying genetic mechanism(s).